Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
52
ESPR Quote, Financials, Valuation and Earnings
Last price:
$3.97
Seasonality move
:
30.02%
Day range:
$3.87 - $4.04
52-week range:
$0.69 - $4.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.57x
P/B ratio:
--
Volume:
2.6M
Avg. volume:
6.4M
1-year change:
71.74%
Market cap:
$936.4M
Revenue:
$332.3M
EPS (TTM):
-$0.54
Earnings Data
Next earnings date for ESPR
Mar 03
2026
Most recent earnings per share
-$0.16
Missed by $0.08
(Nov 6/2025)
Consensus Estimate
-$0.08
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ESPR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/03/2026 | Q4 | $164.7M | -- | -- | $0.28 | -- |
| 11/06/2025 | Q3 | $77.2M | $87.3M | -$0.16 | -$0.08 | -$0.08 |
| 08/05/2025 | Q2 | $63M | $82.4M | -$0.06 | -$0.16 | $0.10 |
| 05/06/2025 | Q1 | $54.2M | $65M | -$0.21 | -$0.15 | -$0.06 |
| 03/04/2025 | Q4 | $61.6M | $69.1M | -$0.11 | -$0.16 | $0.05 |
| 11/07/2024 | Q3 | $51.7M | $51.6M | -$0.15 | -$0.17 | $0.02 |
| 08/12/2024 | Q2 | $47.5M | $73.8M | -$0.33 | -$0.17 | -$0.16 |
| 05/07/2024 | Q1 | $83.9M | $137.7M | $0.32 | -$0.01 | $0.33 |
| 02/27/2024 | Q4 | $28.7M | $32.3M | -$0.50 | -$0.48 | -$0.02 |
| 11/07/2023 | Q3 | -- | $34M | -$0.37 | -- | -- |
| 08/01/2023 | Q2 | -- | $25.8M | -$0.46 | -- | -- |
| 05/09/2023 | Q1 | -- | $24.3M | -$0.79 | -- | -- |
| 02/21/2023 | Q4 | -- | $18.8M | -$0.76 | -- | -- |
| 11/01/2022 | Q3 | -- | $19M | -$0.81 | -- | -- |
| 08/02/2022 | Q2 | -- | $18.8M | -$1.05 | -- | -- |
| 05/03/2022 | Q1 | -- | $18.8M | -$0.93 | -- | -- |
| 02/22/2022 | Q4 | -- | $15.4M | -$1.77 | -- | -- |
| 11/02/2021 | Q3 | -- | $14.4M | -$2.62 | -- | -- |
| 08/03/2021 | Q2 | -- | $40.7M | -$1.67 | -- | -- |
| 05/04/2021 | Q1 | -- | $8M | -$3.50 | -- | -- |
| 02/23/2021 | Q4 | -- | $9.6M | -$3.89 | -- | -- |
| 11/02/2020 | Q3 | -- | $3.8M | -$3.07 | -- | -- |
| 08/10/2020 | Q2 | -- | $212.2M | $4.32 | -- | -- |
| 05/06/2020 | Q1 | -- | $1.8M | -$2.84 | -- | -- |
| 02/27/2020 | Q4 | -- | $982K | -$2.26 | -- | -- |
| 11/06/2019 | Q3 | -- | $981K | -$2.52 | -- | -- |
| 08/08/2019 | Q2 | -- | $982K | -$2.01 | -- | -- |
| 05/08/2019 | Q1 | -- | $145.4M | $3.07 | -- | -- |
| 02/28/2019 | Q4 | -- | -- | -$2.24 | -- | -- |
| 11/01/2018 | Q3 | -- | -- | -$1.86 | -- | -- |
| 08/02/2018 | Q2 | -- | -- | -$1.71 | -- | -- |
| 05/02/2018 | Q1 | -- | -- | -$1.73 | -- | -- |
| 02/20/2018 | Q4 | -- | -- | -$1.44 | -- | -- |
| 11/07/2017 | Q3 | -- | -- | -$1.86 | -- | -- |
| 08/08/2017 | Q2 | -- | -- | -$1.92 | -- | -- |
| 05/04/2017 | Q1 | -- | -- | -$1.80 | -- | -- |
| 02/22/2017 | Q4 | -- | -- | -$1.28 | -- | -- |
| 11/03/2016 | Q3 | -- | -- | -$0.77 | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -$0.62 | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -$0.65 | -- | -- |
| 03/03/2016 | Q4 | -- | -- | -$0.58 | -- | -- |
Esperion Therapeutics, Inc. Earnings Questions
-
How Much did Esperion Therapeutics, Inc. Generate in Revenue Last Quarter?
Esperion Therapeutics, Inc. reported $87.3M worth of top line sales in its most recent quarter.
-
Did Esperion Therapeutics, Inc. Beat Earnings Last Quarter?
Esperion Therapeutics, Inc. announced earnings per share of -$0.16 which represents a miss of analyst forecast a -$0.08 per share.
-
Is Esperion Therapeutics, Inc. Profitable?
Esperion Therapeutics, Inc. reported $46M that represents $0.23 per share over the last quarter.
-
What is the Analyst Consensus for Esperion Therapeutics, Inc. EPS Next Year?
Esperion Therapeutics, Inc.'s earnings are forecast to decrease from -$0.28 per share to -$0.33 per share next year representing a decrease of -75.71%.
-
When is Esperion Therapeutics, Inc.'s Earnings Date?
Esperion Therapeutics, Inc.'s next earnings date is March 3, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
